Synergistic active targeting of dually integrin α v β 3 /CD44-targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies-Reference-Cited by-同舟云学术

Synergistic active targeting of dually integrin α v β 3 /CD44-targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies

Published:2016-08 Issue: Volume:235 Page:1-13
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Shi Sanjun,Zhou Min,Li Xin,Hu Min,Li Chenwen,Li Min,Sheng Fangfang,Li Zhuoheng,Wu Guolin,Luo Minghe,Cui Huanhuan,Li Ziwei,Fu Ruoqiu,Xiang Mingfeng,Xu Jing,Zhang Qian,Lu Laichun

Funder

National Natural Science Foundation of China

Program for “1135” Excellent Talents in Daping Hospital

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference49 articles.

1. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect;Acharya;Adv. Drug Deliv. Rev.,2011

2. Self-assembled hyaluronic acid nanoparticles for active tumor targeting;Choi;Biomaterials,2010

3. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment;Hobbs;Proc. Natl. Acad. Sci. U. S. A.,1998

4. The dawning era of polymer therapeutics;Duncan;Nat. Rev. Drug Discov.,2003

5. Lipid-coated cisplatin nanoparticles induce neighboring effect and exhibit enhanced anticancer efficacy;Guo;ACS Nano,2013

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Invasive metastatic tumor-camouflaged ROS responsive nanosystem for targeting therapeutic brain injury after cardiac arrest;Biomaterials;2024-12

2. Preparation of chitosan-hyaluronic acid microcapsules and its dynamic release behavior analysis in a 3D-printed microchannel system: Exploration and verification;International Journal of Biological Macromolecules;2024-07

3. Hyaluronic acid nanocomposites: Progress in derivatization and in preparation methods for anti-tumor applications;European Polymer Journal;2024-03

4. Therapeutic Approaches of Dual-targeted Nanomedicines for Tumor Multidrug Resistance;Current Drug Delivery;2024-02

5. Inflammation-Driven Nanohitchhiker Enhances Postoperative Immunotherapy by Alleviating Prostaglandin E2-Mediated Immunosuppression;ACS Applied Materials & Interfaces;2024-02-01